Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Bitcoin USD

    70,630.70
    +1,478.45 (+2.14%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,249.60
    +1.11 (+0.02%)
     
  • Dow

    39,754.87
    -5.21 (-0.01%)
     
  • Nasdaq

    16,371.10
    -28.42 (-0.17%)
     
  • Gold

    2,239.70
    +27.00 (+1.22%)
     
  • Crude Oil

    82.79
    +1.44 (+1.77%)
     
  • 10-Yr Bond

    4.2000
    +0.0040 (+0.10%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Chemours to Raise Its Debt: Good or Bad?

Chemours to Raise Its Debt: Good or Bad?

It is now on its way to adding 450 million euros in 4% senior notes due 2026 through a public offering. This offer is managed jointly by Citigroup Global Markets, Deutsche Bank Securities, Merrill Lynch, HSBC Securities, and many others, and the debt includes long-term debt and current maturities. The proceeds from the offer are expected to be ~$557.5 million based on the exchange rate stated in the company’s SEC (Securities and Exchange Commission) filing.